The overarching goal of the study is to improve the surgical treatment outcomes of FAI, which is affecting an increasing number of military personnel and young active individuals in the general population. The proposed study will investigate critical patient, disease, and surgical treatment predictors of FAI surgery outcomes.
Eligibility
Sex
ALL
Min age
14 Years
Max age
40 Years
Healthy volunteers
No
Inclusion Criteria:
1. Age 14 - 40 years
2. Skeletally Mature
3. Failure of 6 weeks of conservative treatment
4. Primary surgery (Hip Arthroscopic Treatment)
a. Surgical treatment of FAI with hip arthroscopy
5. Tonnis 0 -1 OA, with greater than 2 mm of joint space
6. Clinical diagnosis of FAI (cam or combined; alpha \>50 degrees)
Exclusion Criteria:
1. Not a surgical candidate
2. Skeletally Immature
3. Acetabular Dysplasia (LCEA \< 20)
4. Tonnis 2+ OA
5. Previous ipsilateral hip surgery
6. Previous major hip trauma (hip fractures, hip dislocations)
7. Additional disease processes (e.g., Avascular Necrosis (AVN), synovial disease, Ehlers-Danlos Syndrome (EDS), neuromuscular disorders)
8. Unable to consent due to mental faculty
9. Pregnant women
10. Non-English speaking patients
11. Prisoners or other vulnerable populations
Primary outcome measure(s)
Hip disability and Osteoarthritis Outcome Score (HOOS) — Pre operative (Baseline), change from baseline HOOS at 3 months, change from baseline HOOS at 6 months, change from baseline HOOS at 1 year, and change from baseline HOOS at 2 year. HOOS is a questionnaire constructed to assess patient-relevant outcomes in five separate sub-scales (pain, symptoms, activity of daily living, sport and recreation function and hip-related quality of life). HOOS is scored 0-100 with higher scores being the best outcome.
Short Form Health Survey (SF-12) — Pre operative (Baseline), change from baseline SF-12 at 3 months, change from baseline SF-12 at 6 months, change from baseline SF-12 at 1 year, and change from baseline SF-12 at 2 year The SF-12 is a shortened, validated, patient-reported survey of patient health with questions pulled directly from the longer form SF-36. SF-12 is scored 0-100 with higher scores being the best outcome.
Patient-Reported Outcomes Measurement Information System (PROMIS) - Pain Interference (PI) — Pre operative (Baseline), change from baseline PROMIS - PI at 3 months, change from baseline PROMIS - PI at 6 months, change from baseline PROMIS -PI at 1 year, and change from baseline PROMIS - PI at 2 year PROMIS is a set of person-centered measures that evaluates and monitors physical, mental, and social health in adults and children. It can be used with the general population and with individuals living with chronic conditions. This specific PROMIS survey assesses a patient's pain interference. PROMIS - PI is scored from 38.7-83.8 with the lower scores being the best outcome.
Patient-Reported Outcomes Measurement Information System (PROMIS) - Physical Function (PF) — Pre operative (Baseline), change from baseline PROMIS - PF at 3 months, change from baseline PROMIS - PF at 6 months, change from baseline PROMIS -PF at 1 year, and change from baseline PROMIS - PF at 2 year PROMIS is a set of person-centered measures that evaluates and monitors physical, mental, and social health in adults and children. It can be used with the general population and with individuals living with chronic conditions. This specific PROMIS survey assesses a patient's physical function. PROMIS - PF is scored from 14.7-75.6 with the higher scores being the best outcome.
Patient-Reported Outcomes Measurement Information System (PROMIS) - Mobility (M) — Pre operative (Baseline), change from baseline PROMIS - M at 3 months, change from baseline PROMIS - M at 6 months, change from baseline PROMIS -M at 1 year, and change from baseline PROMIS - M at 2 year PROMIS is a set of person-centered measures that evaluates and monitors physical, mental, and social health in adults and children. It can be used with the general population and with individuals living with chronic conditions. This specific PROMIS survey assesses a patient's mobility. PROMIS - M is scored from 18.2-60.2 with the higher scores being the best outcome.
Patient-Reported Outcomes Measurement Information System (PROMIS) - Depression (D) — Pre operative (Baseline), change from baseline PROMIS - D at 3 months, change from baseline PROMIS - D at 6 months, change from baseline PROMIS - D at 1 year, and change from baseline PROMIS - D at 2 year PROMIS is a set of person-centered measures that evaluates and monitors physical, mental, and social health in adults and children. It can be used with the general population and with individuals living with chronic conditions. This specific PROMIS survey assesses a patient's depression. PROMIS - D is scored from 34.2-84.4 with the lower scores being the best outcome.
Patient-Reported Outcomes Measurement Information System (PROMIS) - Anxiety (A) — Pre operative (Baseline), change from baseline PROMIS - A at 3 months, change from baseline PROMIS - A at 6 months, change from baseline PROMIS - A at 1 year, and change from baseline PROMIS - A at 2 year PROMIS is a set of person-centered measures that evaluates and monitors physical, mental, and social health in adults and children. It can be used with the general population and with individuals living with chronic conditions. This specific PROMIS survey assesses a patient's anxiety. PROMIS - A is scored from 32.9-84.9 with the lower scores being the best outcome.
Trial sites (13)
Facility
City
Region
Status
University of Colorado
Aurora
Colorado
University of Iowa
Iowa City
Iowa
Boston Children's Hospital
Boston
Massachusetts
University of Michigan
Ann Arbor
Michigan
Twin Cities Orthopedics
Edina
Minnesota
Mayo Clinic
Rochester
Minnesota
Washington University School of Medicine
St Louis
Missouri
Scottish Rite Hospital for Children
Dallas
Texas
San Antonio Military Medical Center
San Antonio
Texas
University of Wisconsin, Madison
Madison
Wisconsin
Children's Hospital of Eastern Ontario
Ottawa
Ontario
The Ottawa Hospital
Ottawa
Ontario
CHU de Quebec - Universite Laval
Québec
Quebec
More Washington University School of Medicine trials in Canada
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.